Annals of Clinical and Experimental NeurologyAnnals of Clinical and Experimental Neurology2075-54732409-2533Research Center of Neurology1310.17816/psaic13UnknownPrevalence of the risk factors of cerebrovascular disorders in the capital city residents aged 40–59: a clinical and epidemiological studyGnedovskayaElena V.gnedovskaya@mail.ruKravchenkoMikhail A.gnedovskaya@mail.ruProkopovichМ. E.gnedovskaya@mail.ruAndreevaO. S.gnedovskaya@mail.ruSergeevDmitriy V.gnedovskaya@mail.ruOshchepkovaElena V.gnedovskaya@mail.ruVarakinYu. Ya.gnedovskaya@mail.ruPiradovMikhail A.<p>D. Sci. (Med.), Professor, Full Member of the Russian Academy of Sciences, Director</p>gnedovskaya@mail.ruhttps://orcid.org/0000-0002-6338-0392Research Center of NeurologyRussian Cardiology Research Complex02122016104111927012017Copyright © 2016, Gnedovskaya E.V., Kravchenko M.A., Prokopovich M.E., Andreeva O.S., Sergeev D.V., Oshchepkova E.V., Varakin Y.Y., Piradov M.A.2016<p><strong>Introduction.</strong>Circulatory system diseases and cerebrovasculardisorders are among the principal causes of morbidity and mortalityin the Russian Federation. Updated information on prevalenceand structure of the risk factors is needed to elaborate populationwide prevention measures.<br /><strong>The aim</strong>is to assess the prevalence of the risk factors for cerebrovasculardisorders in the working-age population of capital cityresidents and stratification of subjects into the risk groups usingclinical scales for comprehensive evaluation.<br /><strong>Materials and methods.</strong>Thorough screening of the open populationaged 4059 was carried out at one outpatient medical servicefacility in Moscow in 20112012: 376 subjects (156 men,220 women). The analysis took into account gender and agerelateddifferences (in the age groups of 4949 and 5059-yearoldadults).<br /><strong>Results.</strong>We obtained the data on prevalence of the major riskfactors of cerebrovascular disorders, men/women (%): familyhistory 38.5/55.9, smoking 40.4/25.9, low physical activity 48.4/49.5, class 1 obesity 21.8/21.4, class 2 and 3 obesity 6.4/12.7, elevated serum cholesterol levels 32.7/43.2, elevatedserum triglyceride levels 23.1/15.0, hypertension 48.1/45.0,type 2 diabetes 3.8/2.7, increased intima-media thickness in thecarotid and femoral arteries 44.9/65.9, atherosclerotic plaquesof any localization (carotid and/or femoral arteries) 62.8/40.5,and 30% atherosclerotic stenosis of any localization 12.2/7.7. Prevalence of the risk factors in the population and,in some cases, their severity increased with age (before and afterage 50) up to 1.52 fold. When using SCORE and Stroke Riskometer tools for stratification, 8.6% and 39.3% subjects fellinto the high-risk groups, respectively.<br /><strong>Conclusion.</strong>Working-age capital city residents in the 4059 yearscohort show high prevalence of risk factors for cardiovascularand cerebrovascular disorders with the first significant rise ofprevalence after reaching a 50-year age border; hypertension,low physical activity and increased intima-media thickness holdleading positions. The newest Stroke Riskometer appears to bethe most relevant tool for the risk assessing as it has a variety ofundoubted advantages compared to other clinical instruments.</p>risk factorscerebrovascular disordersatherosclerosishypertensionepidemiologyStroke Riskometerфакторы рискацереброваскулярные заболеванияатеросклероз, артериальная гипертонияэпидемиологияРискометр инсульта[Mendis S., Puska P., Norrving B., eds. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva: World Health Organization, 2011; 164. ISBN: 978 92 4 156437 3.][Lozano R., Naghavi M., Foreman K. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2012; 380 (9859): 2095–2128. PMID: 23245604. DOI: 10.1016/S0140-6736(12)61728-0.][Suslina Z.A., Varakin Yu.Ya. Klinicheskoe rukovodstvo po ranney diagnostike, lecheniyu i profilaktike sosudistykh zabolevaniy golovnogo mozga. [Clinical guidelines for the early diagnosis, treatment and prevention of cerebrovascular diseases]. М.: MEDpress-inform, 2015; 380 p. ISBN 978-5-00030-244-6 (In Russ).][Rose G.A., Blackburn H., Gillum R.F., Prineas R.J., eds. Cardiovascular Survey Methods. 2nd ed. Geneva, Switzerland: World Health Organization, 1982. ISBN 978 92 4 156437 3.][Conroy R.M., Pyorala K., Fitzgerald A.P. et al. SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24(11): 987–1003. PMID 12788299 DOI: 10.1016/S0195-668X(03)00114-3.][Parmar P., Krishnamurthi R., Ikram M.A. et al. The Stroke Riskometer( TM) App: Validation of a data collection tool and stroke risk predictor. International journal of stroke: official journal of the International Stroke Society 2015; 10 (2): 231–244. PMID: 25491651 DOI: 10.1111/ijs.12411.][Bots M.L., Hoes A.W., Koudstaal P.J., Hoffman A., Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 1997; 96: 1432–1437. PMID: 9315528][Touboul P.J., Hennerici M.G., Meairs S. et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2007; 23 (1): 75–80. PMID: 17108679 DOI: 10.1159/000097034.][Chazova I.E., Oshchepkova E.V., Zhernakova Yu.V. [Diagnosis and treatment of arterial hypertension. Clinical guidelines]. Kardiologicheskiy vestnik. 2015; 1 (10): 3–30 (In Russ).][Mancia G., Fagard R., Narkiewicz K. et al. ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension 2013, 31 (7): 1281–357. PMID: 23817082 DOI:10.1097/01.hjh.0000431740.32696.cc.][Krasovskiy K.S. [The prevalence of smoking among adults in the Russian Federation]. Kontrol’ nad tabakom i obshchestvennoe zdorov’e v Vostochnoy Evrope 2011; 1 (11): 61–63 (In Russ).][Vereshagin N.V., Suslina Z.A., Piradov M.A. [Principles of diagnosis and treatment of patients with acute ischemic stroke]. Nervnye bolezni 2002; 1: 8–14 (In Russ).][Chazova I.E., Oshchepkova E.V. [The results of implementation of the Federal target program for the prevention and treatment of arterial hypertension in Russia in 2002-2012]. Vestn. Ros. akademii meditsinskikh nauk. 2013; 2: 4–11. DOI: 10.15690/vramn.v68i2.542 (In Russ).][Varlamova T.A., Popova N.A., Naumova V.V. et al. [The results of 10 years of monitoring trends of CVD risk factors and their determinants (MONICA project), among the adult population of Moscow]. In: Nauchno-prakticheskaya konferentsiya “Aktual’nye problemy profilaktiki neinfektsionnykh zabolevaniy”. Materialy [Research and practice conference “Current issues in noncommunicable disease prevention”. Proceedings]. Мoscow; 1995 (In Russ).][Tanashyan M.M., Ionova V.G., Orlov S.V. et al. [Chronic cerebrovascular diseases, metabolic syndrome and the status of hemorrheological and hemostatic systems]. Terapevticheskiy arkhiv. 2010; 10(82): 19–24. PMID: 21341458 (In Russ).][Chazova I.E., Zhernakova Yu.V., Oshchepkova E.V. et al. [Prevalence of cardiiovascular risk factors in Russian population of patients with arterial hypertension]. Kardiologiya 2014; 54 (10): 4–12. DOI:10.18565/cardio.2014.10.4-12 (In Russ).][Kuklina E.V., Carroll M.D., Shaw K.M. et al. Trends in high LDL cholesterol, cholesterol-lowering medication use, and dietary saturated-fat intake: United States, 1976-2010. NCHS Data Brief 2013; 117: 1–8. PMID: 23759124.][Wolf-Maier K., Cooper R.S., Banegas J.R. et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289 (18): 2363-9. PMID: 12746359 DOI: 10.1001/jama.289.18.2363.][Zoni-Berisso M., Lercari F., Carazza T. et al. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014; 6: 213-20. PMID: 24966695 DOI: 10.2147/CLEP.S47385.]